Try our mobile app

Published: 2023-07-27 00:00:00 ET
<<<  go to NATI company page
EX-99.1 2 exhibit99_1.htm EXHIBIT 99.1
Contact:
 
Marissa Vidaurri
   
Vice President of Investor Relations
   
(512) 683-5215


NI Reports Record Revenue for a Second Quarter
Strong execution in challenging macro environment

Q2 2023 Summary
Record GAAP revenue for a second quarter of $417 million, up 5 percent year over year
Solid Q2 GAAP operating margin of 10%
Record Q2 Non-GAAP operating margin of 22%
Strong diluted GAAP EPS of $0.23 and diluted non-GAAP EPS of $0.51

AUSTIN, Texas - July 27, 2023 - National Instruments Corporation (Nasdaq: NATI) today announced Q2 2023 revenue of $417 million, up 5 percent year over year, a record for a second quarter.

In Q2, the total value of the company's orders was down 17 percent year over year. Orders were down 20 percent in the Americas, down 26 percent in APAC, and flat in EMEA year over year.

In Q2, GAAP gross margin was 72 percent and non-GAAP gross margin was 74 percent. Total GAAP operating expenses were $257 million and non-GAAP operating expenses were $218 million. GAAP operating income for Q2 was $41 million with non-GAAP operating income of $91 million. In Q2, GAAP operating margin was 10 percent with non-GAAP operating margin of 22 percent.

In Q2, GAAP net income for Q2 was $30 million and non-GAAP net income was $68 million, with GAAP diluted EPS of $0.23 and non-GAAP diluted EPS of $0.51.

“I am pleased with our results in the second quarter. We delivered record revenue for a second quarter, along with strong operating margin and EPS, which demonstrates the operating leverage we have developed through our ongoing transformation. Revenue was up 5 percent year-over-year and was bolstered by our strong backlog, even as orders weakened more than we initially anticipated throughout the quarter,” said Eric Starkloff, NI President and CEO. “Despite the challenging macro environment, we executed our strategy. Our performance is a testament to our continued focus on high growth subsegments and global execution.”

"Our focus on operational execution and expense management continued, resulting in second quarter GAAP operating margin up over 450 bps and non-GAAP operating margin up over 600 bps as compared to the same quarter last year," said Daniel Berenbaum, NI CFO. "While we still see difficulty in obtaining reliable supply of a few specific parts, a general easing of supply chain constraints combined with the laser-focus of our team enabled more shipments from our strong backlog, offsetting a difficult bookings environment."

As of June 30, 2023, NI had $139 million in cash and cash equivalents. During the second quarter, NI paid $37 million in dividends. The NI Board of Directors approved a quarterly dividend of $0.28 per share payable on August 29, 2023, to stockholders of record on August 8, 2023.
NI's non-GAAP results exclude, as applicable, the impact of purchase accounting fair value adjustments, stock-based compensation, amortization of acquisition-related intangibles, acquisition-related transaction and integration costs, taxes levied on the transfer of acquired intellectual property, foreign exchange loss on acquisitions, restructuring charges, tax reform charges, disposal gains on buildings and related charitable contributions, tax effects related to businesses held for sale, gain on sale of businesses, and capitalization and amortization of internally developed software costs. Reconciliations of the NI's GAAP and non-GAAP results are included as part of this news release.

YTD 2023 Summary
Record GAAP revenue of $854 million, up 9 percent year over year
Strong GAAP operating margin of 11% and record non-GAAP operating margin of 23%
Strong diluted GAAP EPS of $0.58, up 107 percent year over year and record diluted non-GAAP EPS of $1.13, up 47 percent year over year

Non-GAAP Presentation

To supplement NI’s financial statements presented on a GAAP basis, NI has provided non-GAAP financial information, including non-GAAP revenue or net sales, gross profit, gross margin, operating expenses, operating income, operating margin, provision for income taxes, net income, net margin and diluted EPS. A reconciliation of the adjustments to GAAP results is included in the tables below. Non-GAAP financial information is not meant as a substitute for GAAP results, but is included because management believes such information is useful to our investors for informational and comparative purposes. In addition, certain non-GAAP financial information is used internally by management to evaluate and manage the company. The non-GAAP financial information used by NI may differ from that used by other companies. These non-GAAP measures should be considered in addition to, and not as a substitute for, the results prepared in accordance with GAAP.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act that are subject to risks and uncertainties.  These statements include those set forth above relating to our ability to execute on our strategy.  All forward-looking statements are based on current expectations and projections of future events.  We claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 for all forward-looking statements.  Although we believe that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not guarantees of performance and actual results could differ materially from those projected in the forward-looking statements as a result of a number of important factors which could affect our future results and could cause those results or other outcomes to differ materially from those expressed or implied in the forward-looking statements.  Risks and uncertainties include without limitation: the global shortage of key components; effect of the global economic and geopolitical conditions; our international operations and foreign economies; adverse public health matters, including epidemics and pandemics such as the COVID-19 pandemic; our ability to effectively manage our partners and distribution channels; interruptions in our technology systems or cyber-attacks on our systems; the dependency of our product revenue on certain industries and the risk of contractions in such industries; concentration of credit risk and uncertain conditions in the global financial markets; our ability to compete in markets that are highly competitive; our ability to release successful new products or achieve expected returns; the risk that our manufacturing capacity and a substantial majority of our warehousing and distribution capacity are located outside of the U.S.; our dependence on key suppliers and distributors; longer delivery lead times from our suppliers; risk of product liability claims; dependence on our proprietary rights and risks of intellectual property litigation; the continued service of key management, technical personnel and operational employees; our ability to comply with environmental laws and associated costs; our ability to maintain our website; the risks of bugs, vulnerabilities, errors or design flaws in our products; our restructuring activities; our exposure to large orders; our shift to more system orders; our ability to effectively manage our operating expenses and meet budget; fluctuations in our financial results due to factors outside of our control; our outstanding debt; the interest rate risk associated with our variable rate indebtedness; seasonal variation in our revenues; our ability to comply with laws and regulations; changes in tax rates and exposure to additional tax liabilities; our ability to make certain acquisitions or dispositions, integrate the companies we acquire or separate the companies we sold and/or enter into strategic relationships; risks related to currency fluctuations; provisions in charter documents and Delaware law that delay or prevent our acquisition; the timing, receipt and terms and conditions of any required governmental and regulatory approvals of the proposed transaction that could cause the parties to terminate the merger agreement entered into in connection with the proposed transaction; the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement; the risk that the parties to the merger agreement may not be able to satisfy the conditions to the proposed transaction in a timely manner or at all; risks related to disruption of management time from ongoing business operations due to the proposed transaction; the risk that any announcements relating to the proposed transaction could have adverse effects on the market price of our common stock; the risk of any unexpected costs or expenses resulting from the proposed transaction; the risk of any litigation relating to the proposed transaction; the risk that the proposed transaction and its announcement could have an adverse effect on the ability of the Company to retain customers and retain and hire key personnel and maintain relationships with customers, suppliers, employees, stockholders and other business relationships and on its operating results and business generally; and the risk the pending proposed transaction could distract management of the Company.  In addition, our ability to declare and/or pay declared dividends is subject to compliance with the terms of our existing credit agreement. The Company directs readers to its Form 10-K for the year ended December 31, 2022 and the other documents it files with the SEC for other risks associated with the Company’s future performance.  These documents contain and identify important factors that could cause our actual results to differ materially from those contained in our forward-looking statements.  All information in this release is as of the date above.  The Company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the Company’s expectations.

About NI

At NI, we bring together people, ideas and technology so forward thinkers and creative problem solvers can take on humanity’s biggest challenges. From data and automation to research and validation, we provide the tailored, software-connected systems engineers and enterprises need to Engineer Ambitiously™ every day.

National Instruments, NI and ni.com and Engineer Ambitiously are trademarks of National Instruments Corporation. Other product and company names listed are trademarks or trade names of their respective companies. (NATI-F)

National Instruments
 
Condensed Consolidated Balance Sheets
 
(in thousands)
 
 
 
June 30,
   
December 31,
 
 
 
2023
   
2022
 
 
 
(unaudited)
       
Assets
           
Cash and cash equivalents
 
$
139,243
   
$
139,799
 
Accounts receivable, net
   
389,926
     
445,279
 
Inventories, net
   
401,626
     
388,164
 
Prepaid expenses and other current assets
   
123,949
     
115,677
 
Total current assets
   
1,054,744
     
1,088,919
 
Property and equipment, net
   
283,907
     
265,380
 
Goodwill
   
638,459
     
615,734
 
Intangible assets, net
   
192,904
     
200,850
 
Operating lease right-of-use assets
   
68,062
     
59,176
 
Other long-term assets
   
124,918
     
128,479
 
Total assets
 
$
2,362,994
   
$
2,358,538
 
 
               
Liabilities and Stockholders' Equity
               
Accounts payable and accrued expenses
 
$
60,514
   
$
54,639
 
Accrued compensation
   
49,575
     
71,422
 
Deferred revenue - current
   
158,247
     
137,208
 
Operating lease liabilities - current
   
16,608
     
13,834
 
Other taxes payable
   
55,622
     
67,615
 
Debt, current
   
25,000
     
25,000
 
Other current liabilities
   
58,833
     
153,157
 
Total current liabilities
   
424,399
     
522,875
 
Deferred income taxes
   
5,983
     
1,676
 
Income tax payable - non-current
   
22,581
     
40,646
 
Deferred revenue - non-current
   
60,094
     
63,066
 
Operating lease liabilities - non-current
   
36,486
     
30,588
 
Debt - non-current
   
564,373
     
516,637
 
Other long-term liabilities
   
31,558
     
26,926
 
Total liabilities
 
$
1,145,474
   
$
1,202,414
 
                 
Stockholders' equity:
               
Common stock
   
1,328
     
1,310
 
Additional paid-in capital
   
1,251,971
     
1,207,420
 
Retained earnings
   
(11,295
)
   
(14,741
)
Accumulated other comprehensive loss
   
(24,484
)
   
(37,865
)
Total stockholders' equity
   
1,217,520
     
1,156,124
 
Total liabilities and stockholders' equity
 
$
2,362,994
   
$
2,358,538
 


National Instruments
 
Condensed Consolidated Statements of Income
 
(in thousands, except per share data, unaudited)
 
 
                 
 
 
Three Months Ended
   
Six Months Ended
 
 
 
June 30,
   
June 30,
 
 
 
2023
   
2022
   
2023
   
2022
 
 
                       
Net sales:
                       
Product
 
$
379,436
   
$
354,805
   
$
779,835
   
$
698,489
 
Software maintenance
   
37,368
     
40,710
     
73,794
     
82,281
 
Total net sales
   
416,804
     
395,515
     
853,629
     
780,770
 
 
                               
Cost of sales:
                               
Product
   
113,625
     
123,307
     
241,181
     
238,332
 
Software maintenance
   
4,862
     
4,167
     
10,012
     
8,370
 
Total cost of sales
   
118,487
     
127,474
     
251,193
     
246,702
 
 
                               
Gross profit
   
298,317
     
268,041
     
602,436
     
534,068
 
 
   
71.6%

   
67.8%

   
70.6%

   
68.4%

Operating expenses:
                               
Sales and marketing
   
123,101
     
124,908
     
240,443
     
245,064
 
Research and development
   
83,801
     
85,589
     
170,438
     
167,750
 
General and administrative
   
50,504
     
36,772
     
93,719
     
69,949
 
Total operating expenses
   
257,406
     
247,269
     
504,600
     
482,763
 
Operating income
   
40,911
     
20,772
     
97,836
     
51,305
 
Other expense
   
(8,500
)
   
(3,505
)
   
(11,519
)
   
(3,473
)
Income before income taxes
   
32,411
     
17,267
     
86,317
     
47,832
 
Provision for income taxes
   
1,919
     
4,833
     
8,896
     
10,162
 
Net income
 
$
30,492
   
$
12,434
   
$
77,421
   
$
37,670
 
 
                               
Basic earnings per share
 
$
0.23
   
$
0.09
   
$
0.59
   
$
0.29
 
Diluted earnings per share
 
$
0.23
   
$
0.09
   
$
0.58
   
$
0.28
 
 
                               
Weighted average shares outstanding -
                               
Basic
   
132,369
     
131,973
     
131,850
     
132,039
 
Diluted
   
134,171
     
132,708
     
133,693
     
132,948
 
 
                               
Dividends declared per share
 
$
0.28
   
$
0.28
   
$
0.56
   
$
0.56
 

   
Condensed Consolidated Statements of Cash Flows
 
(in thousands, unaudited)
 
   
Six Months Ended June 30,
 
   
2023
   
2022
 
       
Cash flow from operating activities:
           
Net income
 
$
77,421
   
$
37,670
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
   
45,541
     
45,742
 
Stock-based compensation
   
30,388
     
40,804
 
Loss from equity-method investees
   
(5,597
)
   
(131
)
Deferred income taxes
   
2,488
     
943
 
Net change in operating assets and liabilities
   
(75,368
)
   
(169,930
)
Net cash (used in) provided by operating activities
   
74,873
     
(44,902
)
                 
Cash flow from investing activities:
               
Acquisitions, net of cash received
   
(23,024
)
   
(72,802
)
Capital expenditures
   
(35,477
)
   
(24,509
)
Capitalization of internally developed software
   
(925
)
   
(187
)
Additions to other intangibles
   
(3,811
)
   
(2,478
)
Net cash used in  investing activities
   
(63,237
)
   
(99,976
)
                 
Cash flow from financing activities:
               
Proceeds from revolving loan facility
   
120,000
     
175,000
 
Payments on revolving line of credit
   
(60,000
)
   
 
Proceeds from term loan
   
     
 
Payments on term loan
   
(12,500
)
   
 
Debt issuance costs
   
     
 
Proceeds from issuance of common stock
   
17,376
     
17,859
 
Repurchase of common stock
   
     
(70,000
)
Dividends paid
   
(73,975
)
   
(74,034
)
Other
   
(3,075
)
   
 
Net cash used in financing activities
   
(12,174
)
   
48,825
 
                 
Impact of changes in exchange rates on cash
   
(18
)
   
(4,180
)
                 
Net change in cash and cash equivalents
   
(556
)
   
(100,233
)
Cash and cash equivalents at beginning of period
   
139,799
     
211,106
 
Cash and cash equivalents at end of period
 
$
139,243
   
$
110,873
 

The following tables provide details with respect to the amount of GAAP charges related to stock-based compensation, amortization of acquisition-related intangibles and fair value adjustments, acquisition-related transaction and integration costs, capitalization and amortization of internally developed software costs, restructuring charges, gains on sale of business/assets, and other that were recorded in the line items indicated below (unaudited) (in thousands)
 
                         
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
                         
   
2023
   
2022
   
2023
   
2022
 
Stock-based compensation
                       
Cost of sales
 
$
467
   
$
1,253
   
$
1,429
   
$
2,475
 
Sales and marketing
   
5,792
     
7,202
     
10,727
     
14,291
 
Research and development
   
5,146
     
6,271
     
10,264
     
12,359
 
General and administrative
   
3,424
     
5,951
     
7,967
     
11,680
 
Provision for income taxes
   
(6,020
)
   
(1,993
)
   
(7,821
)
   
(4,648
)
Total
 
$
8,809
   
$
18,684
   
$
22,566
   
$
36,157
 
                                 
Amortization of acquisition-related intangibles and fair value adjustments
                               
Net sales
 
$
   
$
371
   
$
   
$
742
 
Cost of sales
   
8,402
     
6,415
     
15,062
     
10,218
 
Sales and marketing
   
4,694
     
5,573
     
9,267
     
11,712
 
Research and development
   
     
     
     
(320
)
Other (expense) income
   
320
     
503
     
753
     
1,019
 
Provision for income taxes
   
(2,014
)
   
(2,094
)
   
(3,505
)
   
(3,530
)
Total
 
$
11,402
   
$
10,768
   
$
21,577
   
$
19,841
 
                                 
Acquisition transaction and integration costs, restructuring charges, and other(1)
                               
Cost of sales
 
$
982
   
$
1,159
   
$
2,502
   
$
1,944
 
Sales and marketing
   
3,225
     
2,339
     
9,169
     
2,646
 
Research and development
   
497
     
487
     
3,735
     
1,102
 
General and administrative
   
16,555
     
1,248
     
24,492
     
3,019
 
Other (expense) income
   
48
     
(265
)
   
(2,449
)
   
(2,132
)
Provision for income taxes
   
(4,569
)
   
(779
)
   
(8,867
)
   
(1,356
)
Total
 
$
16,738
   
$
4,189
   
$
28,582
   
$
5,223
 
(1) Includes costs related to our announced merger with Emerson Electric Co. incurred during the first and second quarter of 2023
 
                                 
(Capitalization) and amortization of internally developed software costs
                               
Cost of sales
 
$
659
   
$
1,896
   
$
1,390
   
$
3,929
 
Research and development
   
     
     
(910
)
   
(187
)
Provision for income taxes
   
(153
)
   
(436
)
   
(132
)
   
(843
)
Total
 
$
506
   
$
1,460
   
$
348
   
$
2,899
 

National Instruments
 
Reconciliation of GAAP to Non-GAAP Measures
 
(in thousands, unaudited)
 
 
                       
   
Three Months Ended
   
Six Months Ended
 
   
June 30,
   
June 30,
 
   
2023
   
2022
   
2023
   
2022
 
                         
Reconciliation of Gross Profit to Non-GAAP Gross Profit
             
Gross profit, as reported
 
$
298,317
   
$
268,041
   
$
602,436
   
$
534,068
 
Stock-based compensation
   
467
     
1,253
     
1,429
     
2,475
 
Amortization of acquisition-related intangibles and fair value adjustments
   
8,402
     
6,786
     
15,062
     
10,960
 
Acquisition transaction and integration costs, restructuring charges and other
   
982
     
1,159
     
2,502
     
1,944
 
Amortization of internally developed software costs
   
659
     
1,896
     
1,390
     
3,929
 
Non-GAAP gross profit
 
$
308,827
   
$
279,135
   
$
622,819
   
$
553,376
 
Non-GAAP gross margin
   
74.1%

   
70.5%

   
73.0%

   
70.8%

                                 
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses
                 
Operating expenses, as reported
 
$
257,406
   
$
247,269
   
$
504,600
   
$
482,763
 
Stock-based compensation
   
(14,362
)
   
(19,424
)
   
(28,958
)
   
(38,330
)
Amortization of acquisition-related intangibles and fair value adjustments
   
(4,694
)
   
(5,573
)
   
(9,267
)
   
(11,392
)
Acquisition transaction and integration costs, restructuring charges and other
   
(20,277
)
   
(4,074
)
   
(37,396
)
   
(6,767
)
Capitalization of internally developed software costs
   
     
     
910
     
187
 
Non-GAAP operating expenses
 
$
218,073
   
$
218,198
   
$
429,889
   
$
426,461
 
                                 
Reconciliation of Operating Income to Non-GAAP Operating Income
                 
Operating income, as reported
 
$
40,911
   
$
20,772
   
$
97,836
   
$
51,305
 
Stock-based compensation
   
14,829
     
20,677
     
30,387
     
40,805
 
Amortization of acquisition-related intangibles and fair value adjustments
   
13,096
     
12,359
     
24,329
     
22,352
 
Acquisition transaction and integration costs, restructuring charges and other
   
21,259
     
5,233
     
39,898
     
8,711
 
Net amortization of internally developed software costs
   
659
     
1,896
     
480
     
3,742
 
Non-GAAP operating income
 
$
90,754
   
$
60,937
   
$
192,930
   
$
126,915
 
Non-GAAP operating margin
   
21.8%

   
15.4%

   
22.6%

   
16.2%

                                 
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes(1)
                 
Provision for income taxes, as reported
 
$
1,919
   
$
4,833
   
$
8,896
   
$
10,162
 
Stock-based compensation
   
6,020
     
1,993
     
7,821
     
4,648
 
Amortization of acquisition-related intangibles and fair value adjustments
   
2,014
     
2,094
     
3,505
     
3,530
 
Acquisition transaction and integration costs, restructuring charges and other
   
4,569
     
779
     
8,867
     
1,356
 
Net amortization of internally developed software costs
   
153
     
436
     
132
     
843
 
Non-GAAP provision for income taxes(1)
 
$
14,675
   
$
10,135
   
$
29,221
   
$
20,539
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 

Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS
 
(in thousands, except per share data, unaudited)
 
 
                       
 
 
Three Months Ended
   
Six Months Ended
 
 
 
June 30,
   
June 30,
 
 
 
2023
   
2022
   
2023
   
2022
 
 
                       
Net income, as reported
 
$
30,492
   
$
12,434
   
$
77,421
   
$
37,670
 
Adjustments to reconcile net income to non-GAAP net income:
                               
  Stock-based compensation
   
14,829
     
20,677
     
30,387
     
40,805
 
Amortization of acquisition-related intangibles and fair value adjustments
   
13,416
     
12,862
     
25,082
     
23,371
 
Acquisition transaction and integration costs, restructuring charges and other
   
21,307
     
4,968
     
37,449
     
6,579
 
Net amortization of internally developed software costs
   
659
     
1,896
     
480
     
3,742
 
Income tax effects and adjustments(1)
   
(12,756
)
   
(5,302
)
   
(20,325
)
   
(10,377
)
Non-GAAP net income
 
$
67,947
   
$
47,535
   
$
150,494
   
$
101,790
 
Non-GAAP net margin
   
16.3%

   
12.0%

   
17.6%

   
13.0%

   
Diluted EPS, as reported
 
$
0.23
   
$
0.09
   
$
0.58
   
$
0.28
 
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
                               
 Stock-based compensation
   
0.11
     
0.16
     
0.23
     
0.31
 
Amortization of acquisition-related intangibles and fair value adjustments
   
0.10
     
0.10
     
0.19
     
0.18
 
Acquisition transaction and integration costs, restructuring charges and other
   
0.16
     
0.04
     
0.28
     
0.05
 
Net amortization of internally developed software costs
   
0.01
     
0.01
     
     
0.03
 
Income tax effects and adjustments(1)
   
(0.10
)
   
(0.04
)
   
(0.15
)
   
(0.08
)
Non-GAAP diluted EPS
 
$
0.51
   
$
0.36
   
$
1.13
   
$
0.77
 
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
 
Weighted average shares outstanding - Diluted
   
134,171
     
132,708
     
133,693
     
132,948